• Skip to main content
  • Skip to after header navigation
  • Skip to site footer

Free-Mail

  • Events
  • Images
    • Instagram Goodness
  • Music
  • News
  • Software

antimalarial

WHO, FDA registered Antimalarial, Pyramax approved for coronavirus clinical trials

South Africa in the news: WHO, FDA registered Antimalarial, Pyramax approved for coronavirus clinical trials: The World Health Organisation prequalified and Ghana Food and Drugs Authority registered Antimalarial Pyramax (Artesunate-Pyronaridine), a fixed-dose combination medication for the treatment of …: “South Africa” – BingNews Starting XIs: Wydad v Chiefs: Kaizer Chiefs will look for their first-ever …

Read moreWHO, FDA registered Antimalarial, Pyramax approved for coronavirus clinical trials

Artemisinin: fighting coronavirus with this antimalarial drug is risky

Artemisinin: fighting coronavirus with this antimalarial drug is risky: Raffi Kojian/Wikimedia Commons, CC BY-SA Since the beginning of the pandemic, much work has been done to test whether antimalarial drugs can treat COVID-19. Hydroxychloroquine, the most well known, has been found to be ineffective. But in Africa, another drug has been attracting attention: artemisinin. Obtained …

Read moreArtemisinin: fighting coronavirus with this antimalarial drug is risky

Genetic surveillance and why it’s critical in the fight against antimalarial drug resistance

Genetic surveillance and why it’s critical in the fight against antimalarial drug resistance: Shutterstock/Warut Prathaksithorn Efforts to tackle malaria infections over the past decades have yielded impressive results across the tropics, so much so that full elimination is now a public health priority for many malaria endemic countries. However, resistance to frontline treatments against malaria …

Read moreGenetic surveillance and why it’s critical in the fight against antimalarial drug resistance

How Africa is helping expand the global antimalarial drug pipeline

How Africa is helping expand the global antimalarial drug pipeline: A scientist at the University of Cape Town's H3D drug discovery centre. Supplied Globally more than three billion people are at risk of contracting malaria. In 2015 alone, an estimated 214 million new cases were recorded. Of these 88% occurred in Africa, which shoulders the …

Read moreHow Africa is helping expand the global antimalarial drug pipeline

Reach Trust

Reach Trust is a holding trust for a number of companies within the Stratlec Group.

Copyright © 2026 · Free-Mail · All Rights Reserved · Powered by Straton Electrical

Back to top